Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications
出版年份 2021 全文链接
标题
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications
作者
关键词
-
出版物
Frontiers in Aging Neuroscience
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-07-08
DOI
10.3389/fnagi.2021.696778
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice
- (2021) Tahir Ali et al. Acta Neuropathologica Communications
- Synthesis and pharmacokinetic study of a 11C-labeled cholesterol 24-hydroxylase inhibitor using ‘in-loop’ [11C]CO2 fixation method
- (2020) Zhen Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Localization of sterols and oxysterols in mouse brain reveals distinct spatial cholesterol metabolism
- (2020) Eylan Yutuc et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glutamate affects cholesterol homeostasis within the brain via the up-regulation of CYP46A1 and ApoE
- (2020) Junjie Zhang et al. TOXICOLOGY
- Epilepsy: key experimental therapeutics in early clinical development
- (2020) Claude Steriade et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Serum 24S-hydroxycholesterol predicts long-term brain structural and functional outcomes after hypoxia-ischemia in neonatal mice
- (2020) Fuxin Lu et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
- (2020) Toshiya Nishi et al. Scientific Reports
- Diverse Immunoregulatory Roles of Oxysterols—The Oxidized Cholesterol Metabolites
- (2020) Chloe Choi et al. Metabolites
- The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System
- (2020) Françoise Piguet et al. HUMAN GENE THERAPY
- 24S‐hydroxycholesterol: Cellular effects and variations in brain diseases
- (2020) Alejandro O. Sodero JOURNAL OF NEUROCHEMISTRY
- Brain cholesterol metabolism and Parkinson's disease
- (2019) Xuemei Huang et al. MOVEMENT DISORDERS
- Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment
- (2019) Raúl Loera-Valencia et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Cholesterol and the Safety Factor for Neuromuscular Transmission
- (2019) Igor Krivoi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons
- (2019) Rik van der Kant et al. Cell Stem Cell
- The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment
- (2019) Alexey M. Petrov et al. FASEB JOURNAL
- Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia
- (2019) Clévio Nóbrega et al. ACTA NEUROPATHOLOGICA
- CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington’s disease
- (2019) Radhia Kacher et al. BRAIN
- CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice
- (2019) Alexey M. Petrov et al. Neurotherapeutics
- Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases
- (2019) Alexey M. Petrov et al. Neurotherapeutics
- NPC 1 enables cholesterol mobilization during long‐term potentiation that can be restored in Niemann–Pick disease type C by CYP 46A1 activation
- (2019) Daniel N Mitroi et al. EMBO REPORTS
- In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds
- (2019) Natalia Mast et al. JOURNAL OF MEDICINAL CHEMISTRY
- Amyloid-β-independent regulators of tau pathology in Alzheimer disease
- (2019) Rik van der Kant et al. NATURE REVIEWS NEUROSCIENCE
- Oxysterols as lipid mediators: Their biosynthetic genes, enzymes and metabolites
- (2019) William J. Griffiths et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Plasma oxysterol profiling in children reveals 24-hydroxycholesterol as a potential marker for Autism Spectrum Disorders
- (2018) S. Grayaa et al. BIOCHIMIE
- Identification of Correlative Shifts in Indices of Brain Cholesterol Metabolism in the C57BL6/Mecp2 tm1.1Bird Mouse, a Model for Rett Syndrome
- (2018) Dieter Lütjohann et al. LIPIDS
- 24S-hydroxycholesterol suppresses neuromuscular transmission in SOD1(G93A) mice: A possible role of NO and lipid rafts
- (2018) Kamilla A. Mukhutdinova et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer’s Disease
- (2018) Ling Li et al. MOLECULAR NEUROBIOLOGY
- The level of 24-hydroxycholesteryl esters decreases in plasma of patients with Parkinson’s disease
- (2018) Concetta Di Natale et al. NEUROSCIENCE LETTERS
- Upregulation of cholesterol 24-hydroxylase following hypoxia–ischemia in neonatal mouse brain
- (2018) Fuxin Lu et al. PEDIATRIC RESEARCH
- Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols
- (2018) Anne Vejux et al. Frontiers in Molecular Neuroscience
- CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content
- (2018) Lydie Boussicault et al. BIOCHIMIE
- Diagnostic Power of 24S-Hydroxycholesterol in Cerebrospinal Fluid: Candidate Marker of Brain Health
- (2018) Valerio Leoni et al. JOURNAL OF ALZHEIMERS DISEASE
- 24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome
- (2018) Ingemar Björkhem et al. Frontiers in Neurology
- Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development
- (2018) Meir Bialer et al. EPILEPSIA
- On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review)
- (2018) Ingemar Björkhem et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Somatic APP gene recombination in Alzheimer’s disease and normal neurons
- (2018) Ming-Hsiang Lee et al. NATURE
- Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons
- (2018) Xiaofei Wei et al. NEUROPHARMACOLOGY
- Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects
- (2017) Nadezda Apostolova et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The mevalonate pathway in neurons: It's not just about cholesterol
- (2017) Miguel Moutinho et al. EXPERIMENTAL CELL RESEARCH
- In vitrocytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds
- (2017) Natalia Mast et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease
- (2017) Natalia Mast et al. NEUROPHARMACOLOGY
- Possible anti-depressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice
- (2017) Tejal K. Patel et al. Pharmacological Reports
- Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1)
- (2017) Natalia Mast et al. PLoS One
- Neuronal Cholesterol Accumulation Induced by Cyp46a1 Down-Regulation in Mouse Hippocampus Disrupts Brain Lipid Homeostasis
- (2017) Sophie Ayciriex et al. Frontiers in Molecular Neuroscience
- Chromatin-Modifying Agents Increase Transcription of CYP46A1, a Key Player in Brain Cholesterol Elimination
- (2017) Inês Milagre et al. JOURNAL OF ALZHEIMERS DISEASE
- Cholesterol 24-hydroxylase: Brain cholesterol metabolism and beyond
- (2016) Miguel Moutinho et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease
- (2016) Lydie Boussicault et al. BRAIN
- The role of cholesterol in membrane fusion
- (2016) Sung-Tae Yang et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology
- (2016) Hui Yang et al. FEBS Journal
- Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity
- (2016) Kyle W. Anderson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices
- (2016) Min-Yu Sun et al. JOURNAL OF NEUROPHYSIOLOGY
- Interdependence of oxysterols with cholesterol profiles in multiple sclerosis
- (2016) Shreya Mukhopadhyay et al. Multiple Sclerosis Journal
- Interdependence of oxysterols with cholesterol profiles in multiple sclerosis
- (2016) Shreya Mukhopadhyay et al. Multiple Sclerosis Journal
- Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation
- (2016) Gabriella Testa et al. Redox Biology
- CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer’s disease
- (2015) Fathia Djelti et al. BRAIN
- Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel
- (2015) Christine M Emnett et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus
- (2015) Farah Chali et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology
- (2015) Marie-Anne Burlot et al. HUMAN MOLECULAR GENETICS
- Efavirenz and the CNS: what we already know and questions that need to be answered
- (2015) Nadezda Apostolova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function
- (2015) Junji Egawa et al. JOURNAL OF PHYSIOLOGY-LONDON
- Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis
- (2015) Lenka Novakova et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival
- (2015) Min-Yu Sun et al. NEUROSCIENTIST
- Cholesterol Homeostasis Failure in the Brain: Implications for Synaptic Dysfunction and Cognitive Decline
- (2014) Marco Segatto et al. CURRENT MEDICINAL CHEMISTRY
- Different oxysterols have opposing actions at N-methyl-d-aspartate receptors
- (2014) Andrew J. Linsenbardt et al. NEUROPHARMACOLOGY
- Efavirenz Promotes β-Secretase Expression and Increased Aβ1-40,42 via Oxidative Stress and Reduced Microglial Phagocytosis: Implications for HIV Associated Neurocognitive Disorders (HAND)
- (2014) Lecia A. M. Brown et al. PLoS One
- Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid
- (2013) Valerio Leoni et al. BIOCHEMICAL PHARMACOLOGY
- Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1
- (2013) Natalia Mast et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacologic Stimulation of Cytochrome P450 46A1 and Cerebral Cholesterol Turnover in Mice
- (2013) Natalia Mast et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of N-Methyl-D-Aspartate Receptors
- (2013) S. M. Paul et al. JOURNAL OF NEUROSCIENCE
- Spatiotemporal Dynamics of Phosphorylation in Lipid Second Messenger Signaling
- (2013) Corina E. Antal et al. MOLECULAR & CELLULAR PROTEOMICS
- Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis
- (2013) C van de Kraats et al. Multiple Sclerosis Journal
- Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression
- (2013) Valerio Leoni et al. NEUROBIOLOGY OF DISEASE
- NMDA receptors in nervous system diseases
- (2013) Qiang Zhou et al. NEUROPHARMACOLOGY
- Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease
- (2013) Ingemar Björkhem et al. NEUROSCIENCE LETTERS
- Is It Possible to Improve Memory Function by Upregulation of the Cholesterol 24S-Hydroxylase (CYP46A1) in the Brain?
- (2013) Silvia Maioli et al. PLoS One
- 24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases
- (2012) Valerio Leoni et al. BIOCHIMIE
- Cholesterol loss during glutamate-mediated excitotoxicity
- (2012) Alejandro O Sodero et al. EMBO JOURNAL
- Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease
- (2012) Julius Popp et al. JOURNAL OF NEUROCHEMISTRY
- Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study
- (2011) Giovanni Zuliani et al. BMC Neurology
- Neuronal differentiation alters the ratio of Sp transcription factors recruited to the CYP46A1 promoter
- (2011) Inês Milagre et al. JOURNAL OF NEUROCHEMISTRY
- Cholesterol metabolism in Huntington disease
- (2011) Joanna M. Karasinska et al. Nature Reviews Neurology
- Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency
- (2011) Johannes Häberle Therapeutics and Clinical Risk Management
- Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain
- (2010) Natalia Mast et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIRT1 Modulation as a Novel Approach to the Treatment of Diseases of Aging
- (2010) Charles A. Blum et al. JOURNAL OF MEDICINAL CHEMISTRY
- Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington’s disease
- (2010) Daniel Del Toro et al. JOURNAL OF NEUROCHEMISTRY
- Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression ofCYP46A1gene transcription
- (2010) Maria João Nunes et al. JOURNAL OF NEUROCHEMISTRY
- Memantine Preferentially Blocks Extrasynaptic over Synaptic NMDA Receptor Currents in Hippocampal Autapses
- (2010) P. Xia et al. JOURNAL OF NEUROSCIENCE
- Cellular stress from excitatory neurotransmission contributes to cholesterol loss in hippocampal neurons aging in vitro
- (2010) Alejandro O. Sodero et al. NEUROBIOLOGY OF AGING
- Cholesterol 24-Hydroxylase: An Enzyme of Cholesterol Turnover in the Brain
- (2009) David W. Russell et al. Annual Review of Biochemistry
- The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo
- (2009) Marjan Shafaati et al. JOURNAL OF LIPID RESEARCH
- Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats
- (2009) Katja Nieweg et al. JOURNAL OF NEUROCHEMISTRY
- Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease
- (2009) Eloise Hudry et al. MOLECULAR THERAPY
- Different Patterns of Oxidized Lipid Products in Plasma and Urine of Dengue Fever, Stroke, and Parkinson's Disease Patients: Cautions in the Use of Biomarkers of Oxidative Stress
- (2008) Chung-Yung J. Lee et al. ANTIOXIDANTS & REDOX SIGNALING
- Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors
- (2008) Marjan Shafaati et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease
- (2008) Valerio Leoni et al. BRAIN
- Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain
- (2008) Denise M.O. Ramirez et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Transcriptional regulation of the humanCYP46A1brain-specific expression by Sp transcription factors
- (2008) Ins Milagre et al. JOURNAL OF NEUROCHEMISTRY
- Cortical Injury Increases Cholesterol 24S Hydroxylase (Cyp46) Levels in the Rat Brain
- (2008) Casandra M. Cartagena et al. JOURNAL OF NEUROTRAUMA
- Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation
- (2008) T. Kotti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain
- (2008) N. Mast et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now